İsmail TOPAL, Faruk KARAKEÇİLİ, Orçun BARKAY

Aşı Öncesi ve Sonrası Dönemde Suçiçeği Olgularının Özellikleri

GİRİŞ ve AMAÇ: Suçiçeği, duyarlı bireylerde generalize ekzantematöz döküntü ile karakterize, çocukluk döneminde sık görülen bir klinik tablodur. YÖNTEM ve GEREÇLER: Ülkemizde suçiçeği aşısının çocukluk çağı rutin aşılama takvimine alındığı 2013 yılından önceki ve sonraki dönemlerde gelişen olguların demografik, klinik-laboratuvar özelliklerinin değerlendirilmesi ve kıyaslanması amaçlanmıştır. BULGULAR: : Bu çalışma, Ocak 1994-Nisan 1997 tarihleri arasında Dr. Sami Ulus Çocuk Sağlığı ve Hastalıkları Merkezi’nde tanı alan 502 (1. grup), Ocak 2016-2020 tarihleri arasında Mengücek Gazi Eğitim ve Araştırma Hastanesi’nde tanı alan 170 (2. grup) suçiçeği olgusunun retrospektif incelenmesi ile yapılmıştır. TARTIŞMA ve SONUÇ: İki grupta da hastaların çoğunluğu erkeklerden oluşmaktaydı (%57 vs %54.2). Ortalama yaş birinci grupta 4.4 (±3) iken ikinci grupta 6.8 (±3.6) idi. Ana gruplardaki hastalar yaşlarına göre 0-4, 5-10, 11-15 yaş grubu olmak üzere 3’er alt gruba ayrıldı. Buna göre; birinci ve ikinci gruptaki hastaların çoğunluğunu 0-4 yaş grubu hastalar oluşturmaktaydı. Birinci gruptan 47, ikinci gruptan ise 5 hasta hastaneye yatırılarak izlenmişti. Birinci gruptaki en sık komplikasyonlar alt solunum yolu enfeksiyonu ve deri-yumuşak doku enfeksiyonuydu. İkinci gruptaki en sık komplikasyon ise alt solunum yolu enfeksiyonuydu. Sonuç: Bildirilen ve komplikasyon gelişen olgu sayısında aşılama sonrasında anlamlı oranda azalma saptanması, aşı karşıtlığının giderek arttığı bu dönemde ciddi önem arz etmektedir.

Characteristics of Chickenpox Cases before and After Vaccination

INTRODUCTION: Chickenpox is a common clinical picture in childhood, characterized by a generalized exanthematous rash in susceptible individuals. METHODS: It was aimed to evaluate and compare the demographic, clinical-laboratory characteristics of cases that developed in our country before and after 2013 when the chickenpox vaccine was included in the routine childhood vaccination calendar. RESULTS: This study was conducted by retrospective examination of 502 chikenpox cases diagnosed at Dr. Sami Ulus Child Health and Diseases Center between January 1994-April 1997 (1st group) and 170 cases at Mengücek Gazi Training and Research Hospital between January 2016-2020 (2nd group). DISCUSSION AND CONCLUSION: Most of the patients were males in both groups (57% vs 54.2%). The mean age was 4.4 (± 3) in the first group and 6.8 (± 3.6) in the second group. The patients in the main groups were divided into 3 subgroups, as 0-4, 5-10, and 11-15 age groups. According to this; most of the patients in the first and second groups were in the 0-4 age group. 47 patients from the first group and 5 patients from the second group were hospitalized. The most common complications in the first group were lower respiratory tract infection and skin-soft tissue infection and in the second group was lower respiratory tract infection. Conclusion: The significant decrease in the number of reported cases and complications after vaccination is really important in this period of anti-vaccination thoughts are gradually increasing.

PDF

___

1. Tsintsof A, Delprado WJ, Keogh AM. Varicella zoster myocarditis progressing to cardiyomyopathy and cardiac transplantation. Br Hearth J 1993; 70: 93-5.

2. Clinical features of varicella-zoster virus infection: Chickenpox. Uptodate.com. Erişim Tarihi: 06.02.2020

3. Feigin RD, Cherry JD. Textbook of pediatric infections Diseases. Philadelphia; WB saunders CO, 1981; p.1206-31, p.684- 721.

4. Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002; 186 Suppl 1:S91.

5. Laupland KB, Davies HD, Low DE, et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105:E60.

6. de Benedictis FM, Osimani P. Necrotising fasciitis complicating varicella. Arch Dis Child 2008; 93:619.

7. Shirley R, Mackey S, Meagher P. Necrotising fasciitis: a sequelae of varicella zoster infection. J Plast Reconstr Aesthet Surg 2011; 64:123.

8. Vugia DJ, Peterson CL, Meyers HB, et al. Invasive group A streptococcal infections in children with varicella in Southern California. Pediatr Infect Dis J 1996; 15:146.

9. Zurawski CA, Bardsley M, Beall B, et al. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis 1998; 27:150.

10. Marin M, Watson TL, Chaves SS, et al. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis 2008; 197 Suppl 2:S94.

11. Straus SE, Ostrove JM, Inchauspé G, et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108:221.

12. Johnson R, Milbourn PE. Central nervous system manifestations of chickenpox. Can Med Assoc J 1970; 102:831.

13. Brunell PA. Textbook of pediatric infectious diseases. Philadelphia; WB saunders 1987; p.1602-7.

14. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996; 10:571.

15. Heininger U, Seward JF. Varicella. Lancet 2006; 368:1365.

16. Balfour HH Jr, Bean B, Laskin OL, et al. Acyclovir halts progression of herpes zoster in immunocompromised. N Engl J Med 1993; 308: 1448-53.

17. Guess HA, Broughton DD, Melton LJ 3rd, et al. Chickenpox hospitalizations among residents of Olmsted County, Minnesota, 1962 through 1981. A population-basedstudy. Am J Dis Child 1984; 138: 1055-7.

18. García-Doval I, Pérez-Zafrilla B, Descalzo MA, et al. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis 2010; 69:1751.

19. Anderson DR, Schwartz J, Hunter NJ, et al. Varicella hepatitis: a fatalcase in a previously healthy, immunocompetent adult. Report of a case, autopsy, and review of the literature. Arch Intern Med 1994; 154: 2101-6.

20. Eshchen J, Reif L. Waron M, et al. Hepatic lesion in chickenpox. Gastroenterology 1973; 64: 462-6.

21. Nathas S, Pang AS, Singh Sıdhu DS, et al. Necrotising soft tissue infections as a complication of chickenpox. Singapore Med J 1995; 36: 656-60.

22. Uğur C, Say AZ. Suçiçeği ve komplikasyonlarının değerlendirilmesi. Zeynep Kamil Tıp Bülteni 2018; 49(2); 205-8

23. Krugma S. VZV infection. Infectious diseases of children. Toronata: the CV Mosby CO 1985; p.433-50.

24. Spackova M, Muehlen M, Siedlar A. Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J 2010; 29(9):884-6.

25. Rafila A, Pitigoi D, Arama A, et al. The clinical and epidemiological evolution of varicella in Romania during 2004 and 2013. J Med Life 2015; 8(1):16-20.

26. Blumental S, Sabbe M, Lepage P, et al. Varicella Paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child 2016;101:16-22.

27. Dilek M, Helvacı M, Aksu N. Suçiçeği komplikasyonlarının değerlendirilmesi. Abant Med J 2015; 4(4):360-5.

28. Marchetto S, de Benedictis FM, de Martino M, et al. Epidemiology of hospital admissions for chickenpox in children: an Italian multicenter study in the pre-vaccine era. Acta Paediatr 2007;96(10):1490-3.

29. Chaves SS, Zhang J, Civen R, et al. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005. J Infect Dis 2008; 197 Suppl 2:S127.

30. Weinmann S, Chun C, Mullooly JP, et al. Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis 2008; 197 Suppl 2:S132.

31. Bullowa JE, Wishick SM. Complications of varicella. Am J Dis Child 1939; 49: 923.

32. Mermelstein RH, Freireich AW. Varicella pneumonia. Ann Intern Med 1963; 55: 456-63.

33. Peterson CL, Mascola L, Chao SM, et al. Children hospitalized for varicella: A prevaccine review. J Pediatr 1996; 129: 529-36.